Background: Locally advanced non-small cell lung cancer (LA-NSCLC) needs a multidisciplinary management and patients undergoing an intentional to treat pathway have also a high risk of recurrence even after neoadjuvant chemotherapy followed by curative resection. Recently, perioperative chemoimmunotherapy (CIO) changed the treatment paradigm. However, literature is lacking in the comparison of the post-operative outcomes in elderly patients. The aim of this study was to assess the postoperative results of perioperative CIO in patients aged ≥70 years. Methods: We conducted a single-center retrospective analysis on patients with clinical stage IIB–IIIB NSCLC who underwent treatment between January 2015 and June 2025. We compared post-operative outcomes of patients who received perioperative CIO with a control group of patients who received standard chemotherapy stratifying the study population focusing on elderly patients. Results: In the study period we identified 174 patients with stage IIB–IIIB NSCLC underwent lung surgery after standard chemotherapy (n=121) or CIO (n=53) and among these elderly represented 42.9% and 32.1% respectively. Ninety-day mortality was 2.4% vs. 0%. At least one complication was observed in 47.9% vs. 32.1%, P=0.07, whereas major complications (Clavien-Dindo > 3b) were developed in 11.5% vs. 1%, respectively (P=0.07). In the elderly population, major complications were observed in 13.46% vs. 0% (P=0.02). Pneumonectomy and DLCO% less than 60% of the predicted were associated with an increased risk of complications at the univariate analysis, whereas video-assisted thoracoscopic surgery (VATS) and CIO were associated with a decrease. The multivariable analysis model did not show any significant predictive factor for the development of post-operative complications. Conclusions: Lung resection after perioperative CIO is feasible and safe even in elderly patients, without major or life-threatening complications.

Post-operative outcomes of lung resection after perioperative chemoimmunotherapy for stage IIB–IIIB non-small-cell lung cancer in the elderly: a single center real-life experience / Bongiolatti S., Mugnaini G., Viggiano D., Gatteschi L., Tombelli S., Mazzoni F., Caliman E., Fancelli S., Frongia F., Gonfiotti A., Voltolini L.. - In: JOURNAL OF THORACIC DISEASE. - ISSN 2072-1439. - ELETTRONICO. - 18:(2026), pp. 381.381-381.381. [10.21037/jtd-2025-aw-2048]

Post-operative outcomes of lung resection after perioperative chemoimmunotherapy for stage IIB–IIIB non-small-cell lung cancer in the elderly: a single center real-life experience

Bongiolatti S.;Caliman E.;Fancelli S.;Gonfiotti A.;Voltolini L.
2026

Abstract

Background: Locally advanced non-small cell lung cancer (LA-NSCLC) needs a multidisciplinary management and patients undergoing an intentional to treat pathway have also a high risk of recurrence even after neoadjuvant chemotherapy followed by curative resection. Recently, perioperative chemoimmunotherapy (CIO) changed the treatment paradigm. However, literature is lacking in the comparison of the post-operative outcomes in elderly patients. The aim of this study was to assess the postoperative results of perioperative CIO in patients aged ≥70 years. Methods: We conducted a single-center retrospective analysis on patients with clinical stage IIB–IIIB NSCLC who underwent treatment between January 2015 and June 2025. We compared post-operative outcomes of patients who received perioperative CIO with a control group of patients who received standard chemotherapy stratifying the study population focusing on elderly patients. Results: In the study period we identified 174 patients with stage IIB–IIIB NSCLC underwent lung surgery after standard chemotherapy (n=121) or CIO (n=53) and among these elderly represented 42.9% and 32.1% respectively. Ninety-day mortality was 2.4% vs. 0%. At least one complication was observed in 47.9% vs. 32.1%, P=0.07, whereas major complications (Clavien-Dindo > 3b) were developed in 11.5% vs. 1%, respectively (P=0.07). In the elderly population, major complications were observed in 13.46% vs. 0% (P=0.02). Pneumonectomy and DLCO% less than 60% of the predicted were associated with an increased risk of complications at the univariate analysis, whereas video-assisted thoracoscopic surgery (VATS) and CIO were associated with a decrease. The multivariable analysis model did not show any significant predictive factor for the development of post-operative complications. Conclusions: Lung resection after perioperative CIO is feasible and safe even in elderly patients, without major or life-threatening complications.
2026
18
381
381
Goal 3: Good health and well-being
Bongiolatti S.; Mugnaini G.; Viggiano D.; Gatteschi L.; Tombelli S.; Mazzoni F.; Caliman E.; Fancelli S.; Frongia F.; Gonfiotti A.; Voltolini L....espandi
File in questo prodotto:
File Dimensione Formato  
jtd-18-04-381.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Creative commons
Dimensione 447.07 kB
Formato Adobe PDF
447.07 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1500439
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact